{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T18:40:09Z","timestamp":1729968009549,"version":"3.28.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,26]]},"DOI":"10.7759\/cureus.72437","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T18:19:22Z","timestamp":1729966762000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of Steroid Therapy in Preventing Recurrence of Atrial Fibrillation After Ablation: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Nava R","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saral","family":"Lamichhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudarshan","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalasa","family":"Pokhrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlon E","family":"Rivera Boadla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajog","family":"Kansakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Basnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabal","family":"KC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakriti","family":"Lamichhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Cunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.012004","article-title":"Atrial fibrillation and mechanisms of stroke","volume":"47","author":"Kamel H","year":"2016","unstructured":"Kamel H, Okin PM, Elkind MSV, Iadecola C. Atrial fibrillation and mechanisms of stroke. Stroke. 2016, 47:895-900. 10.1161\/STROKEAHA.115.012004","journal-title":"Stroke"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102181","article-title":"Atrial fibrillation and stroke: State-of-the-art and future directions","volume":"49","author":"Elsheikh S","year":"2024","unstructured":"Elsheikh S, Hill A, Irving G, Lip GY, Abdul-Rahim AH. Atrial fibrillation and stroke: State-of-the-art and future directions. Curr Probl Cardiol. 2024, 49:102181. 10.1016\/j.cpcardiol.2023.102181","journal-title":"Curr Probl Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: Novel methods and new insights","volume":"127","author":"Kornej J","year":"2020","unstructured":"Kornej J, B\u00f6rschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: Novel methods and new insights. Circ Res. 2020, 127:4-20. 10.1161\/CIRCRESAHA.120.316340","journal-title":"Circ Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-019-00158-2","article-title":"Catheter ablation of atrial fibrillation: State of the art and future perspectives","volume":"9","author":"Rottner L","year":"2020","unstructured":"Rottner L, Bellmann B, Lin T, et al.. Catheter ablation of atrial fibrillation: State of the art and future perspectives. Cardiol Ther. 2020, 9:45-58. 10.1007\/s40119-019-00158-2","journal-title":"Cardiol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad244","article-title":"Progress in atrial fibrillation ablation during 25 years of Europace journal","volume":"25","author":"Boersma L","year":"2023","unstructured":"Boersma L, Andrade JG, Betts T, et al.. Progress in atrial fibrillation ablation during 25 years of Europace journal. Europace. 2023, 25:euad244. 10.1093\/europace\/euad244","journal-title":"Europace"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.862164","article-title":"Role of inflammation in the pathogenesis of atrial fibrillation","volume":"13","author":"Ihara K","year":"2022","unstructured":"Ihara K, Sasano T. Role of inflammation in the pathogenesis of atrial fibrillation. Front Physiol. 2022, 13:862164. 10.3389\/fphys.2022.862164","journal-title":"Front Physiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-13-3466","article-title":"Inflammation and C-reactive protein in atrial fibrillation: Cause or effect?","volume":"41","author":"Galea R","year":"2014","unstructured":"Galea R, Cardillo MT, Caroli A, Marini MG, Sonnino C, Narducci ML, Biasucci LM. Inflammation and C-reactive protein in atrial fibrillation: Cause or effect?. Tex Heart Inst J. 2014, 41:461-8. 10.14503\/THIJ-13-3466","journal-title":"Tex Heart Inst J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/joa3.12077","article-title":"Inflammation and atrial fibrillation: A comprehensive review","volume":"34","author":"Korantzopoulos P","year":"2018","unstructured":"Korantzopoulos P, Letsas KP, Tse G, Fragakis N, Goudis CA, Liu T. Inflammation and atrial fibrillation: A comprehensive review. J Arrhythm. 2018, 34:394-401. 10.1002\/joa3.12077","journal-title":"J Arrhythm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.054","article-title":"Role of inflammation in initiation and perpetuation of atrial fibrillation: A systematic review of the published data","volume":"50","author":"Issac TT","year":"2007","unstructured":"Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: A systematic review of the published data. J Am Coll Cardiol. 2007, 50:2021-8. 10.1016\/j.jacc.2007.06.054","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"18","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med. 2021, 18:e1003583. 10.1371\/journal.pmed.1003583","journal-title":"PLoS Med"},{"key":"ref11","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.4.1. The Cochrane Collaboration, 2020. http.\/\/revman.cochrane.org."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2013.07.037","article-title":"Corticosteroid use during pulmonary vein isolation is associated with a higher prevalence of dormant pulmonary vein conduction","volume":"10","author":"Andrade JG","year":"2013","unstructured":"Andrade JG, Khairy P, Nattel S, et al.. Corticosteroid use during pulmonary vein isolation is associated with a higher prevalence of dormant pulmonary vein conduction. Heart Rhythm. 2013, 10:1569-75. 10.1016\/j.hrthm.2013.07.037","journal-title":"Heart Rhythm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-12-0728","article-title":"Effect of a single bolus injection of low-dose hydrocortisone for prevention of atrial fibrillation recurrence after radiofrequency catheter ablation","volume":"77","author":"Won H","year":"2013","unstructured":"Won H, Kim JY, Shim J, Uhm JS, Pak HN, Lee MH, Joung B. Effect of a single bolus injection of low-dose hydrocortisone for prevention of atrial fibrillation recurrence after radiofrequency catheter ablation. Circ J. 2013, 77:53-9. 10.1253\/circj.cj-12-0728","journal-title":"Circ J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2015.56.2.324","article-title":"Comparison of two different doses of single bolus steroid injection to prevent atrial fibrillation recurrence after radiofrequency catheter ablation","volume":"56","author":"Kim DR","year":"2015","unstructured":"Kim DR, Won H, Uhm JS, et al.. Comparison of two different doses of single bolus steroid injection to prevent atrial fibrillation recurrence after radiofrequency catheter ablation. Yonsei Med J. 2015, 56:324-31. 10.3349\/ymj.2015.56.2.324","journal-title":"Yonsei Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07271-2","article-title":"Single-dose intraprocedural steroid administration does not impact early atrial fibrillation recurrence","volume":"37","author":"Agboola KM","year":"2023","unstructured":"Agboola KM, Dietrich M, Karki R, et al.. Single-dose intraprocedural steroid administration does not impact early atrial fibrillation recurrence. Cardiovasc Drugs Ther. 2023, 37:151-7. 10.1007\/s10557-021-07271-2","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.04.057","article-title":"Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: A randomized controlled trial","volume":"56","author":"Koyama T","year":"2010","unstructured":"Koyama T, Tada H, Sekiguchi Y, et al.. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: A randomized controlled trial. J Am Coll Cardiol. 2010, 56:1463-72. 10.1016\/j.jacc.2010.04.057","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.002957","article-title":"Effect of short-term steroid therapy on early recurrence during the blanking period after catheter ablation of atrial fibrillation","volume":"8","author":"Kim YR","year":"2015","unstructured":"Kim YR, Nam GB, Han S, et al.. Effect of short-term steroid therapy on early recurrence during the blanking period after catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2015, 8:1366-72. 10.1161\/CIRCEP.115.002957","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.1604","article-title":"Use of oral steroid and its effects on atrial fibrillation recurrence and inflammatory cytokines post ablation - The Steroid AF Study","volume":"9","author":"Iskandar S","year":"2017","unstructured":"Iskandar S, Reddy M, Afzal MR, et al.. Use of oral steroid and its effects on atrial fibrillation recurrence and inflammatory cytokines post ablation - The Steroid AF Study. J Atr Fibrillation. 2017, 9:1604. 10.4022\/jafib.1604","journal-title":"J Atr Fibrillation"},{"key":"ref19","unstructured":"Corticosteroid pulse after ablation (SAAB). (2019). Accessed. September 29, 2024: https:\/\/clinicaltrials.gov\/study\/NCT00807586?cond=NCT00807586&rank=1&tab=history&a=5#version-content-panel."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010006","article-title":"Atrial fibrillation: Pathogenesis, predisposing factors, and genetics","volume":"23","author":"Sagris M","year":"2021","unstructured":"Sagris M, Vardas EP, Theofilis P, Antonopoulos AS, Oikonomou E, Tousoulis D. Atrial fibrillation: Pathogenesis, predisposing factors, and genetics. Int J Mol Sci. 2021, 23:6. 10.3390\/ijms23010006","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-314267","article-title":"Mechanisms of atrial fibrillation","volume":"105","author":"Wijesurendra RS","year":"2019","unstructured":"Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation. Heart. 2019, 105:1860-7. 10.1136\/heartjnl-2018-314267","journal-title":"Heart"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00347-9","article-title":"Atrial fibrillation","volume":"8","author":"Brundel BJ","year":"2022","unstructured":"Brundel BJ, Ai X, Hills MT, Kuipers MF, Lip GY, de Groot NM. Atrial fibrillation. Nat Rev Dis Primers. 2022, 8:21. 10.1038\/s41572-022-00347-9","journal-title":"Nat Rev Dis Primers"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2017.1355237","article-title":"Persistent atrial fibrillation vs paroxysmal atrial fibrillation: Differences in management","volume":"15","author":"Margulescu AD","year":"2017","unstructured":"Margulescu AD, Mont L. Persistent atrial fibrillation vs paroxysmal atrial fibrillation: Differences in management. Expert Rev Cardiovasc Ther. 2017, 15:601-18. 10.1080\/14779072.2017.1355237","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jce.15759","article-title":"Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review)","volume":"34","author":"Bizhanov KA","year":"2023","unstructured":"Bizhanov KA, \u0410bzaliyev KB, Baimbetov AK, Sarsenbayeva AB, Lyan E. Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review). J Cardiovasc Electrophysiol. 2023, 34:153-65. 10.1111\/jce.15759","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2024.05.007","article-title":"Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective","author":"Yamaguchi T","year":"2024","unstructured":"Yamaguchi T. Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective. J Cardiol. 2024, S0914-5087(24)00096-0. 10.1016\/j.jjcc.2024.05.007","journal-title":"J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1270452","article-title":"Research on atrial fibrillation mechanisms and prediction of therapeutic prospects: Focus on the autonomic nervous system upstream pathways","volume":"10","author":"Huang J","year":"2023","unstructured":"Huang J, Wu B, Qin P, Cheng Y, Zhang Z, Chen Y. Research on atrial fibrillation mechanisms and prediction of therapeutic prospects: Focus on the autonomic nervous system upstream pathways. Front Cardiovasc Med. 2023, 10:1270452. 10.3389\/fcvm.2023.1270452","journal-title":"Front Cardiovasc Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0604-9","article-title":"Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes","volume":"16","author":"Karam BS","year":"2017","unstructured":"Karam BS, Chavez-Moreno A, Koh W, Akar JG, Akar FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017, 16:120. 10.1186\/s12933-017-0604-9","journal-title":"Cardiovasc Diabetol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu YF","year":"2015","unstructured":"Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015, 12:230-43. 10.1038\/nrcardio.2015.2","journal-title":"Nat Rev Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.122.318179","article-title":"Regulation of VWF (Von Willebrand factor) in inflammatory thrombosis","volume":"42","author":"Manz XD","year":"2022","unstructured":"Manz XD, Bogaard HJ, Aman J. Regulation of VWF (Von Willebrand factor) in inflammatory thrombosis. Arterioscler Thromb Vasc Biol. 2022, 42:1307-20. 10.1161\/ATVBAHA.122.318179","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.548631","article-title":"Platelets as mediators of neuroinflammation and thrombosis","volume":"11","author":"Rawish E","year":"2020","unstructured":"Rawish E, Nording H, M\u00fcnte T, Langer HF. Platelets as mediators of neuroinflammation and thrombosis. Front Immunol. 2020, 11:548631. 10.3389\/fimmu.2020.548631","journal-title":"Front Immunol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2174\/15701611113116660165","article-title":"Inflammatory biomarkers and atrial fibrillation: Potential role of inflammatory pathways in the pathogenesis of atrial fibrillation-induced thromboembolism","volume":"13","author":"Guo Y","year":"2015","unstructured":"Guo Y, Lip GY, Apostolakis S. Inflammatory biomarkers and atrial fibrillation: Potential role of inflammatory pathways in the pathogenesis of atrial fibrillation-induced thromboembolism. Curr Vasc Pharmacol. 2015, 13:192-201. 10.2174\/15701611113116660165","journal-title":"Curr Vasc Pharmacol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12266","article-title":"The dual role of platelet-innate immune cell interactions in thrombo-inflammation","volume":"4","author":"Rayes J","year":"2020","unstructured":"Rayes J, Bourne JH, Brill A, Watson SP. The dual role of platelet-innate immune cell interactions in thrombo-inflammation. Res Pract Thromb Haemost. 2020, 4:23-35. 10.1002\/rth2.12266","journal-title":"Res Pract Thromb Haemost"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221097383","article-title":"Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA","volume":"28","author":"Yang Y","year":"2022","unstructured":"Yang Y, Feng G, Yan J, et al.. Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA. Clin Appl Thromb Hemost. 2022, 28:10760296221097383. 10.1177\/10760296221097383","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-165845","article-title":"D-dimer antigen: Current concepts and future prospects","volume":"113","author":"Adam SS","year":"2009","unstructured":"Adam SS, Key NS, Greenberg CS. D-dimer antigen: Current concepts and future prospects. Blood. 2009, 113:2878-87. 10.1182\/blood-2008-06-165845","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2174\/1389450120666190715102510","article-title":"Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis","volume":"20","author":"Urano T","year":"2019","unstructured":"Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ. Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis. Curr Drug Targets. 2019, 20:1695-701. 10.2174\/1389450120666190715102510","journal-title":"Curr Drug Targets"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2014.12.002","article-title":"Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: A systematic review and meta-analysis","volume":"31","author":"Wu N","year":"2015","unstructured":"Wu N, Chen X, Cai T, et al.. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: A systematic review and meta-analysis. Can J Cardiol. 2015, 31:278-86. 10.1016\/j.cjca.2014.12.002","journal-title":"Can J Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020274","article-title":"The association between coagulation and atrial fibrillation","volume":"12","author":"Rafaqat S","year":"2024","unstructured":"Rafaqat S, Gluscevic S, Patoulias D, Sharif S, Klisic A. The association between coagulation and atrial fibrillation. Biomedicines. 2024, 12:274. 10.3390\/biomedicines12020274","journal-title":"Biomedicines"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11040915","article-title":"Role of new potential biomarkers in the risk of thromboembolism in atrial fibrillation","volume":"11","author":"Pezzo MP","year":"2022","unstructured":"Pezzo MP, Tufano A, Franchini M. Role of new potential biomarkers in the risk of thromboembolism in atrial fibrillation. J Clin Med. 2022, 11:915. 10.3390\/jcm11040915","journal-title":"J Clin Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010535","article-title":"Developing pharmacological therapies for atrial fibrillation targeting mitochondrial dysfunction and oxidative stress: A scoping review","volume":"25","author":"Menezes J\u00fanior AD","year":"2023","unstructured":"Menezes J\u00fanior AD, Fran\u00e7a-E-Silva AL, Oliveira JM, Silva DM. Developing pharmacological therapies for atrial fibrillation targeting mitochondrial dysfunction and oxidative stress: A scoping review. Int J Mol Sci. 2023, 25:535. 10.3390\/ijms25010535","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123824","article-title":"The role of NADPH oxidases and oxidative stress in neurodegenerative disorders","volume":"19","author":"Tarafdar A","year":"2018","unstructured":"Tarafdar A, Pula G. The role of NADPH oxidases and oxidative stress in neurodegenerative disorders. Int J Mol Sci. 2018, 19:3824. 10.3390\/ijms19123824","journal-title":"Int J Mol Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122322","article-title":"Antioxidant supplementation in oxidative stress-related diseases: What have we learned from studies on alpha-tocopherol?","volume":"11","author":"Meulmeester FL","year":"2022","unstructured":"Meulmeester FL, Luo J, Martens LG, Mills K, van Heemst D, Noordam R. Antioxidant supplementation in oxidative stress-related diseases: What have we learned from studies on alpha-tocopherol?. Antioxidants (Basel). 2022, 11:2322. 10.3390\/antiox11122322","journal-title":"Antioxidants (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle A","year":"2017","unstructured":"Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017, 120:229-43. 10.1161\/CIRCRESAHA.116.308537","journal-title":"Circ Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2006.04.026","article-title":"The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation","volume":"115","author":"Korantzopoulos P","year":"2007","unstructured":"Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007, 115:135-43. 10.1016\/j.ijcard.2006.04.026","journal-title":"Int J Cardiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01751-5","article-title":"Atrial fibrillation ablation strategies and technologies: Past, present, and future","volume":"110","author":"Buist TJ","year":"2021","unstructured":"Buist TJ, Zipes DP, Elvan A. Atrial fibrillation ablation strategies and technologies: Past, present, and future. Clin Res Cardiol. 2021, 110:775-88. 10.1007\/s00392-020-01751-5","journal-title":"Clin Res Cardiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s00399-021-00836-6","article-title":"Late arrhythmia recurrence after atrial fibrillation ablation: Incidence, mechanisms and clinical implications","volume":"33","author":"Erhard N","year":"2022","unstructured":"Erhard N, Metzner A, Fink T. Late arrhythmia recurrence after atrial fibrillation ablation: Incidence, mechanisms and clinical implications. Herzschrittmacherther Elektrophysiol. 2022, 33:71-6. 10.1007\/s00399-021-00836-6","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2023.2257131","article-title":"Catheter ablation of atrial fibrillation: Anticipating and avoiding complications","volume":"20","author":"Kisling AJ","year":"2023","unstructured":"Kisling AJ, Symons JG, Daubert JP. Catheter ablation of atrial fibrillation: Anticipating and avoiding complications. Expert Rev Med Devices. 2023, 20:929-41. 10.1080\/17434440.2023.2257131","journal-title":"Expert Rev Med Devices"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.065","article-title":"Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug\u00a0therapy in the CABANA Trial","volume":"75","author":"Poole JE","year":"2020","unstructured":"Poole JE, Bahnson TD, Monahan KH, et al.. Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug\u00a0therapy in the CABANA Trial. J Am Coll Cardiol. 2020, 75:3105-18. 10.1016\/j.jacc.2020.04.065","journal-title":"J Am Coll Cardiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins D","year":"2004","unstructured":"Atkins D, Best D, Briss PA, et al.. Grading quality of evidence and strength of recommendations. BMJ. 2004, 328:1490. 10.1136\/bmj.328.7454.1490","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300317-role-of-steroid-therapy-in-preventing-recurrence-of-atrial-fibrillation-after-ablation-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T18:19:25Z","timestamp":1729966765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300317-role-of-steroid-therapy-in-preventing-recurrence-of-atrial-fibrillation-after-ablation-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.72437","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,26]]}}}